Fundraising Fox

Phigenix

Atlanta, US · Georgia corporation

phigenix.com

Phigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.

BiotechHealthtechMedical Devices

Founders & leadership

CD
CARLTON D. DONALD, PH.DFounder
WH
WENNIFER H. DONALDExecutive
WH
Wennifer Holmes DonaldNamed on SEC filing
CD
Carlton D. Donald, Ph.DNamed on SEC filing
KE
Kenneth E. Robinson, M.D.Named on SEC filing
CD
Cynthia DayNamed on SEC filing

Board

RA
RICHARD A. ROY, M.D.Board director
CN
CYNTHIA N. DAYBoard director
KE
KENNETH E. ROBINSON, M.D.Board director

Reported raises · per SEC filings

Form D private placements

$4.6M disclosed across 2 rounds · 2007–2014

$842.4KraisedAug 2015 · 14 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • WENNIFER H. DONALDExecutive Officer, Director
  • CARLTON D. DONALD, PH.DExecutive Officer, Director
  • RICHARD A. ROY, M.D.Director
  • CYNTHIA N. DAYDirector
  • KENNETH E. ROBINSON, M.D.Director
Offering amount
$10.5M
Amount sold
$842.4K
Minimum investment
$35K
First sale
Sep 2014
Incorporated
Corporation, Georgia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.7MraisedAug 2014 · 78 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wennifer Holmes DonaldDirector
  • Carlton D. Donald, Ph.DExecutive Officer, Director
  • Kenneth E. Robinson, M.D.Director
  • Cynthia DayDirector
Offering amount
$3.7M
Amount sold
$3.7M
Minimum investment
$15K
First sale
Mar 2007
Incorporated
Corporation, Georgia
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Phigenix for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Phigenix do?
Phigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
Who founded Phigenix?
Phigenix was founded by CARLTON D. DONALD, PH.D.
How much funding has Phigenix raised?
Phigenix has disclosed $4.6M raised across 2 rounds.
Where is Phigenix headquartered?
Phigenix is headquartered in Atlanta, US.